1. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature reviews Drug discovery. 2010;9(3):203-14. Epub 2010/02/20.
2. Schuhmacher A, Gassmann O, Hinder M. Changing R&D models in research-based pharmaceutical companies. Journal of translational medicine. 2016;14(1):105. Epub 2016/04/28.
3. Schomaker S, Ramaiah S, Khan N, Burkhardt J. Safety biomarker applications in drug development. The Journal of toxicological sciences. 2019;44(4):225-35. Epub 2019/04/05.
4. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics. 2001;69(3):89-95. Epub 2001/03/10.
5. Ozer JS, Dieterle F, Troth S, Perentes E, Cordier A, Verdes P, et al. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nature biotechnology. 2010;28(5):486-94. Epub 2010/05/12.
6. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annual review of pharmacology and toxicology. 2008;48:463-93. Epub 2007/10/17.
7. Griffin BR, Faubel S, Edelstein CL. Biomarkers of Drug-Induced Kidney Toxicity. Therapeutic drug monitoring. 2019;41(2):213-26. Epub 2019/03/19.
8. Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011-2012. Nature reviews Drug discovery. 2013;12(8):569. Epub 2013/08/02.
9. Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, et al. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nature reviews Drug discovery. 2014;13(6):419-31. Epub 2014/05/17.
10. Takasuna K, Hagiwara T, Hirohashi M, Kato M, Nomura M, Nagai E, et al. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer research. 1996;56(16):3752-7. Epub 1996/08/15.
11. Acharya C, Sahingur SE, Bajaj JS. Microbiota, cirrhosis, and the emerging oral-gut-liver axis. JCI insight. 2017;2(19). Epub 2017/10/06.
12. Kakiuchi-Kiyota S, Koza-Taylor PH, Mantena SR, Nelms LF, Enayetallah AE, Hollingshead BD, et al. Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice. Toxicological sciences : an official journal of the Society of Toxicology. 2014;138(1):234-48. Epub 2013/12/18.
13. Swayze EE, Siwkowski AM, Wancewicz EV, Migawa MT, Wyrzykiewicz TK, Hung G, et al. Antisense oligonucleotides containing locked nucleic acid improve potency but cause significant hepatotoxicity in animals. Nucleic acids research. 2007;35(2):687-700. Epub 2006/12/22.
14. Nathwani RA, Pais S, Reynolds TB, Kaplowitz N. Serum alanine aminotransferase in skeletal muscle diseases. Hepatology. 2005;41(2):380-2. Epub 2005/01/22.
15. Crenn P, Vahedi K, Lavergne-Slove A, Cynober L, Matuchansky C, Messing B. Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology. 2003;124(5):1210-9. Epub 2003/05/06.
16. Trennery PN, Waring RH. Early changes in thioacetamide-induced liver damage. Toxicology letters. 1983;19(3):299-307. Epub 1983/12/01.
17. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicology. 2008;245(3):194-205. Epub 2008/02/23.
18. Vijaya S, Nagarajan B. Arginine metabolism in rat liver after hepatic damage. Biochemical medicine. 1982;27(1):86-94. Epub 1982/02/01.
19. Jenkinson CP, Grody WW, Cederbaum SD. Comparative properties of arginases. Comparative biochemistry and physiology Part B, Biochemistry & molecular biology. 1996;114(1):107-32. Epub 1996/05/01.
20. Houdijk AP, Teerlink T, Visser JJ, van Lambalgen AA, van Leeuwen PA. Arginine deficiency in bile duct-ligated rats after surgery: the role of plasma arginase and gut endotoxin restriction. Gastroenterology. 1997;113(4):1375-83. Epub 1997/10/10.
21. Roth E, Steininger R, Winkler S, Langle F, Grunberger T, Fugger R, et al. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism. Transplantation. 1994;57(5):665-9. Epub 1994/03/15.
22. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. Blockade of the Larginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. Hepatology. 2002;36(3):573-81. Epub 2002/08/29.
23. Wu G, Morris SM, Jr. Arginine metabolism: nitric oxide and beyond. The Biochemical journal. 1998;336 ( Pt 1):1-17. Epub 1998/11/10.
24. Ishihara K, Katsutani N, Aoki T. A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats. Basic & clinical pharmacology & toxicology. 2006;99(3):251-60. Epub 2006/08/26.
25. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, et al. Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. The Journal of biological chemistry. 2006;281(24):16768-76. Epub 2006/04/13.
26. Chen C, Krausz KW, Idle JR, Gonzalez FJ. Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. The Journal of biological chemistry. 2008;283(8):4543-59. Epub 2007/12/21.
27. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical chemistry. 2009;81(16):6656-67. Epub 2009/07/25.
28. Takei M, Ando Y, Saitoh W, Tanimoto T, Kiyosawa N, Manabe S, et al. Ethylene glycol monomethyl ether-induced toxicity is mediated through the inhibition of flavoprotein dehydrogenase enzyme family. Toxicological sciences : an official journal of the Society of Toxicology. 2010;118(2):643-52. Epub 2010/07/10.
29. Cao Q, Batey R, Pang G, Russell A, Clancy R. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A. Immunology and cell biology. 1998;76(6):542-9. Epub 1999/01/20.
30. Copple BL, Banes A, Ganey PE, Roth RA. Endothelial cell injury and fibrin deposition in rat liver after monocrotaline exposure. Toxicological sciences : an official journal of the Society of Toxicology. 2002;65(2):309-18. Epub 2002/01/29.
31. Desmet VJ, Krstulovic B, Van Damme B. Histochemical study of rat liver in alphanaphthyl isothiocyanate (ANIT) induced cholestasis. The American journal of pathology. 1968;52(2):401-21. Epub 1968/02/01.
32. Waters NJ, Holmes E, Williams A, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on the time-related metabolic effects of alphanaphthylisothiocyanate on liver, urine, and plasma in the rat: an integrative metabonomic approach. Chemical research in toxicology. 2001;14(10):1401-12. Epub 2001/10/16.
33. Pluskal T, Castillo S, Villar-Briones A, Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC bioinformatics. 2010;11:395. Epub 2010/07/24.
34. Murayama H, Ikemoto M, Fukuda Y, Tsunekawa S, Nagata A. Advantage of serum typeI arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats. Clinica chimica acta; international journal of clinical chemistry. 2007;375(1-2):63-8. Epub 2006/07/29.
35. Murayama H, Ikemoto M, Fukuda Y, Nagata A. Superiority of serum type-I arginase and ornithine carbamyltransferase in the detection of toxicant-induced acute hepatic injury in rats. Clinica chimica acta; international journal of clinical chemistry. 2008;391(1-2):31-5. Epub 2008/02/19.
36. Yamazaki M, Miyake M, Sato H, Masutomi N, Tsutsui N, Adam KP, et al. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats. Toxicology and applied pharmacology. 2013;268(1):79-89. Epub 2013/01/31.
37. Frohlich J, Seccombe DW, Hahn P, Dodek P, Hynie I. Effect of fasting on free and esterified carnitine levels in human serum and urine: correlation with serum levels of free fatty acids and beta-hydroxybutyrate. Metabolism: clinical and experimental. 1978;27(5):555-61. Epub 1978/05/01.
38. Nagasawa T, Yoshizawa F, Nishizawa N. Plasma N tau-methylhistidine concentration is a sensitive index of myofibrillar protein degradation during starvation in rats. Bioscience, biotechnology, and biochemistry. 1996;60(3):501-2. Epub 1996/03/01.
39. Bloxam DL. Nutritional aspects of amino acid metabolism. 2. The effects of starvation on hepatic portal-venous differences in plasma amino acid concentration and on liver amino acid concentrations in the rat. The British journal of nutrition. 1972;27(2):233-47. Epub 1972/03/01.
40. Holecek M, Kovarik M. Alterations in protein metabolism and amino acid concentrations in rats fed by a high-protein (casein-enriched) diet - effect of starvation. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2011;49(12):3336-42. Epub 2011/10/04.
41. Robertson DG, Ruepp SU, Stryker SA, Hnatyshyn SY, Shipkova PA, Aranibar N, et al. Metabolomic and transcriptomic changes induced by overnight (16 h) fasting in male and female Sprague-Dawley rats. Chemical research in toxicology. 2011;24(4):481-7. Epub 2011/03/09.
42. McGuire DM, Gross MD, Elde RP, van Pilsum JF. Localization of L-arginine-glycine amidinotransferase protein in rat tissues by immunofluorescence microscopy. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 1986;34(4):429-35. Epub 1986/04/01.
43. Van Pilsum JF, Stephens GC, Taylor D. Distribution of creatine, guanidinoacetate and enzymes for their biosynthesis in the animal kingdom. Implications for phylogeny. The Biochemical journal. 1972;126(2):325-45. Epub 1972/01/01.
44. Sjolander A, Magnusson KE, Latkovic S. Morphological changes of rat small intestine after short-time exposure to concanavalin A or wheat germ agglutinin. Cell structure and function. 1986;11(3):285-93. Epub 1986/09/01.
45. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27(3):328-39. Epub 2008/04/29.
46. Ozturk F, Ucar M, Ozturk IC, Vardi N, Batcioglu K. Carbon tetrachloride-induced nephrotoxicity and protective effect of betaine in Sprague-Dawley rats. Urology. 2003;62(2):353-6. Epub 2003/08/02.
47. John-Baptiste A, Huang W, Kindt E, Wu A, Vitsky A, Scott W, et al. Evaluation of potential gastrointestinal biomarkers in a PAK4 inhibitor-treated preclinical toxicity model to address unmonitorable gastrointestinal toxicity. Toxicologic pathology. 2012;40(3):482-90. Epub 2012/03/08.
48. Barzal JA, Szczylik C, Rzepecki P, Jaworska M, Anuszewska E. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage. Acta biochimica Polonica. 2014;61(4):615-31. Epub 2014/12/05.
49. van de Poll MC, Ligthart-Melis GC, Boelens PG, Deutz NE, van Leeuwen PA, Dejong CH. Intestinal and hepatic metabolism of glutamine and citrulline in humans. The Journal of physiology. 2007;581(Pt 2):819-27. Epub 2007/03/10.
50. Windmueller HG, Spaeth AE. Source and fate of circulating citrulline. The American journal of physiology. 1981;241(6):E473-80. Epub 1981/12/01.
51. Boukhettala N, Leblond J, Claeyssens S, Faure M, Le Pessot F, Bole-Feysot C, et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. American journal of physiology Endocrinology and metabolism. 2009;296(1):E182-90. Epub 2008/11/06.
52. Gutierrez IM, Fisher JG, Ben-Ishay O, Jones BA, Kang KH, Hull MA, et al. Citrulline levels following proximal versus distal small bowel resection. Journal of pediatric surgery. 2014;49(5):741-4. Epub 2014/05/24.
53. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM. Citrulline-based assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology. 2010;21(8):1706-11. Epub 2010/01/22.
54. Lutgens LC, Deutz NE, Gueulette J, Cleutjens JP, Berger MP, Wouters BG, et al. Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiationinduced small bowel damage. International journal of radiation oncology, biology, physics. 2003;57(4):1067-74. Epub 2003/10/25.
55. Kume S, Yamato M, Tamura Y, Jin G, Nakano M, Miyashige Y, et al. Potential biomarkers of fatigue identified by plasma metabolome analysis in rats. PloS one. 2015;10(3):e0120106. Epub 2015/03/21.
56. Coeffier M, Claeyssens S, Hecketsweiler B, Lavoinne A, Ducrotte P, Dechelotte P. Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. American journal of physiology Gastrointestinal and liver physiology. 2003;285(2):G266-73. Epub 2003/04/19.
57. Samuels SE, Taillandier D, Aurousseau E, Cherel Y, Le Maho Y, Arnal M, et al. Gastrointestinal tract protein synthesis and mRNA levels for proteolytic systems in adult fasted rats. The American journal of physiology. 1996;271(2 Pt 1):E232-8. Epub 1996/08/01.
58. Saitoh W, Yamauchi S, Watanabe K, Takasaki W, Mori K. Metabolomic analysis of arginine metabolism in acute hepatic injury in rats. The Journal of toxicological sciences. 2014;39(1):41-50. Epub 2014/01/15.
59. Ginguay A, Cynober L, Curis E, Nicolis I. Ornithine Aminotransferase, an Important Glutamate-Metabolizing Enzyme at the Crossroads of Multiple Metabolic Pathways. Biology. 2017;6(1). Epub 2017/03/09.
60. Leung KT, Chan KY, Ma TP, Yu JW, Tong JH, Tam YH, et al. Dysregulated expression of arginine metabolic enzymes in human intestinal tissues of necrotizing enterocolitis and response of CaCO2 cells to bacterial components. The Journal of nutritional biochemistry. 2016;29:64-72. Epub 2016/02/21.
61. Yao Y, Zhang P, Wang J, Chen J, Wang Y, Huang Y, et al. Dissecting Target Toxic Tissue and Tissue Specific Responses of Irinotecan in Rats Using Metabolomics Approach. Frontiers in pharmacology. 2017;8:122. Epub 2017/03/28.
62. Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. International journal of molecular sciences. 2017;18(5). Epub 2017/05/13.
63. Ceballos I, Chauveau P, Guerin V, Bardet J, Parvy P, Kamoun P, et al. Early alterations of plasma free amino acids in chronic renal failure. Clinica chimica acta; international journal of clinical chemistry. 1990;188(2):101-8. Epub 1990/04/30.
64. Viant MR, Ebbels TMD, Beger RD, Ekman DR, Epps DJT, Kamp H, et al. Use cases, best practice and reporting standards for metabolomics in regulatory toxicology. Nature communications. 2019;10(1):3041. Epub 2019/07/12.
65. Goldstein RA. Skeletal Muscle Injury Biomarkers: Assay Qualification Efforts and Translation to the Clinic. Toxicologic pathology. 2017;45(7):943-51. Epub 2017/11/23.
66. Richir MC, Siroen MP, van Elburg RM, Fetter WP, Quik F, Nijveldt RJ, et al. Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. The British journal of nutrition. 2007;97(5):906-11. Epub 2007/03/27.
67. Marini JC, Didelija IC, Castillo L, Lee B. Plasma arginine and ornithine are the main citrulline precursors in mice infused with arginine-free diets. The Journal of nutrition. 2010;140(8):1432-7. Epub 2010/06/25.
68. Breuillard C, Cynober L, Moinard C. Citrulline and nitrogen homeostasis: an overview. Amino acids. 2015;47(4):685-91. Epub 2015/02/14.
69. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, et al. Arginine metabolism and nutrition in growth, health and disease. Amino acids. 2009;37(1):153-68. Epub 2008/11/26.
70. Morris SM, Jr. Arginine metabolism: boundaries of our knowledge. The Journal of nutrition. 2007;137(6 Suppl 2):1602S-9S. Epub 2007/05/22.
71. Scott JA, North ML, Rafii M, Huang H, Pencharz P, Grasemann H. Plasma arginine metabolites reflect airway dysfunction in a murine model of allergic airway inflammation. J Appl Physiol (1985). 2015;118(10):1229-33. Epub 2015/05/17.
72. Kovamees O, Shemyakin A, Pernow J. Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction. Diabetes & vascular disease research. 2016;13(5):354-60. Epub 2016/05/18.
73. Caldwell RW, Rodriguez PC, Toque HA, Narayanan SP, Caldwell RB. Arginase: A Multifaceted Enzyme Important in Health and Disease. Physiological reviews. 2018;98(2):641-65. Epub 2018/02/08.
74. Peters JH, Wierdsma NJ, Teerlink T, van Leeuwen PA, Mulder CJ, van Bodegraven AA. Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity. The American journal of gastroenterology. 2007;102(12):2814-9. Epub 2007/09/04.
75. Holecek M, Skalska H, Mraz J. Plasma amino acid levels after carbon tetrachloride induced acute liver damage. A dose-response and time-response study in rats. Amino acids. 1999;16(1):1-11. Epub 1999/03/17.
76. Tharakan JF, Yu YM, Zurakowski D, Roth RM, Young VR, Castillo L. Adaptation to a long term (4 weeks) arginine- and precursor (glutamate, proline and aspartate)-free diet. Clin Nutr. 2008;27(4):513-22. Epub 2008/07/02.
77. Li R, Dai J, Kang H. The construction of a panel of serum amino acids for the identification of early chronic kidney disease patients. Journal of clinical laboratory analysis. 2018;32(3). Epub 2017/06/24.
78. Sailer M, Dahlhoff C, Giesbertz P, Eidens MK, de Wit N, Rubio-Aliaga I, et al. Increased plasma citrulline in mice marks diet-induced obesity and may predict the development of the metabolic syndrome. PloS one. 2013;8(5):e63950. Epub 2013/05/22.
79. Church RJ, Kullak-Ublick GA, Aubrecht J, Bonkovsky HL, Chalasani N, Fontana RJ, et al. Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort. Hepatology. 2019;69(2):760-73. Epub 2018/01/23.
80. Thulin P, Hornby RJ, Auli M, Nordahl G, Antoine DJ, Starkey Lewis P, et al. A longitudinal assessment of miR-122 and GLDH as biomarkers of drug-induced liver injury in the rat. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2017;22(5):461-9. Epub 2016/12/17.
81. Flanigan KM, Voit T, Rosales XQ, Servais L, Kraus JE, Wardell C, et al. Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: results of a double-blind randomized clinical trial. Neuromuscular disorders : NMD. 2014;24(1):16-24. Epub 2013/12/11.
82. McGill MR. The past and present of serum aminotransferases and the future of liver injury biomarkers. EXCLI journal. 2016;15:817-28. Epub 2016/01/01.
83. Sharapova T, Devanarayan V, LeRoy B, Liguori MJ, Blomme E, Buck W, et al. Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies. Veterinary pathology. 2016;53(1):211-21. Epub 2015/07/01.
84. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(11):4402-7. Epub 2009/02/28.
85. Gaskell H, Ge X, Nieto N. High-Mobility Group Box-1 and Liver Disease. Hepatology communications. 2018;2(9):1005-20. Epub 2018/09/12.
86. Antoine DJ, Williams DP, Kipar A, Jenkins RE, Regan SL, Sathish JG, et al. Highmobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. Toxicological sciences : an official journal of the Society of Toxicology. 2009;112(2):521-31. Epub 2009/09/29.
87. Antoine DJ, Dear JW, Lewis PS, Platt V, Coyle J, Masson M, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777-87. Epub 2013/02/08.
88. Antoine DJ, Jenkins RE, Dear JW, Williams DP, McGill MR, Sharpe MR, et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. Journal of hepatology. 2012;56(5):1070-9. Epub 2012/01/24.
89. Church RJ, Watkins PB. The transformation in biomarker detection and management of drug-induced liver injury. Liver international : official journal of the International Association for the Study of the Liver. 2017;37(11):1582-90. Epub 2017/04/08.
90. Kalabat DY, Vitsky A, Scott W, Kindt E, Hayes K, John-Baptiste A, et al. Identification and Evaluation of Novel MicroRNA Biomarkers in Plasma and Feces Associated with Druginduced Intestinal Toxicity. Toxicologic pathology. 2017;45(2):302-20. Epub 2016/05/18.
91. Shen LJ, Guan YY, Wu XP, Wang Q, Wang L, Xiao T, et al. Serum citrulline as a diagnostic marker of sepsis-induced intestinal dysfunction. Clinics and research in hepatology and gastroenterology. 2015;39(2):230-6. Epub 2014/12/03.
92. Miyoshi J, Miyamoto H, Goji T, Taniguchi T, Tomonari T, Sogabe M, et al. Serum diamine oxidase activity as a predictor of gastrointestinal toxicity and malnutrition due to anticancer drugs. Journal of gastroenterology and hepatology. 2015;30(11):1582-90. Epub 2015/05/15.
93. Moriyama K, Kouchi Y, Morinaga H, Irimura K, Hayashi T, Ohuchida A, et al. Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs. Toxicology. 2006;217(2-3):233-9. Epub 2005/11/10.
94. Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, Pogorzelska J, Prokopowicz D. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regulatory peptides. 2008;147(1-3):25-8. Epub 2008/01/19.
95. Zhang ZQ, Meng H, Wang N, Liang LN, Liu LN, Lu SM, et al. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma. Diagnostic pathology. 2014;9:135. Epub 2014/07/06.
96. Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'Keefe S J, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology. 2012;143(6):1473-81 e3. Epub 2012/09/18.
97. Yamaguchi N, Mahbub MH, Takahashi H, Hase R, Ishimaru Y, Sunagawa H, et al. Plasma free amino acid profiles evaluate risk of metabolic syndrome, diabetes, dyslipidemia, and hypertension in a large Asian population. Environmental health and preventive medicine. 2017;22(1):35. Epub 2017/11/23.
98. Yamakado M, Nagao K, Imaizumi A, Tani M, Toda A, Tanaka T, et al. Plasma Free Amino Acid Profiles Predict Four-Year Risk of Developing Diabetes, Metabolic Syndrome, Dyslipidemia, and Hypertension in Japanese Population. Scientific reports. 2015;5:11918. Epub 2015/07/15.
99. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PloS one. 2011;6(9):e24143. Epub 2011/09/15.
100. Benito S, Sanchez-Ortega A, Unceta N, Jansen JJ, Postma G, Andrade F, et al. Plasma biomarker discovery for early chronic kidney disease diagnosis based on chemometric approaches using LC-QTOF targeted metabolomics data. Journal of pharmaceutical and biomedical analysis. 2018;149:46-56. Epub 2017/11/04.
101. Soga T, Sugimoto M, Honma M, Mori M, Igarashi K, Kashikura K, et al. Serum metabolomics reveals gamma-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease. Journal of hepatology. 2011;55(4):896-905. Epub 2011/02/22.
102. Takeuchi K, Ohishi M, Endo K, Suzumura K, Naraoka H, Ohata T, et al. Hydroxyproline, a serum biomarker candidate for gastric ulcer in rats: a comparison study of metabolic analysis of gastric ulcer models induced by ethanol, stress, and aspirin. Biomarker insights. 2014;9:61-6. Epub 2014/08/16.
103. Thompson KL, Zhang J, Stewart S, Rosenzweig BA, Shea K, Mans D, et al. Comparison of urinary and serum levels of di-22:6-bis(monoacylglycerol)phosphate as noninvasive biomarkers of phospholipidosis in rats. Toxicology letters. 2012;213(2):285-91. Epub 2012/07/26.
104. Liu N, Tengstrand EA, Chourb L, Hsieh FY. Di-22:6-bis(monoacylglycerol)phosphate: A clinical biomarker of drug-induced phospholipidosis for drug development and safety assessment. Toxicology and applied pharmacology. 2014;279(3):467-76. Epub 2014/06/27.
105. Trivedi DK, Hollywood KA, Goodacre R. Metabolomics for the masses: The future of metabolomics in a personalized world. New horizons in translational medicine. 2017;3(6):294-305. Epub 2017/11/03.
106. Kao CC, Cope JL, Hsu JW, Dwarkanath P, Karnes JM, Luna RA, et al. The Microbiome, Intestinal Function, and Arginine Metabolism of Healthy Indian Women Are Different from Those of American and Jamaican Women. The Journal of nutrition. 2016. Epub 2016/03/11.
107. Dirin M, Winkler J. Influence of diverse chemical modifications on the ADME characteristics and toxicology of antisense oligonucleotides. Expert opinion on biological therapy. 2013;13(6):875-88. Epub 2013/03/05.
108. Burdick AD, Sciabola S, Mantena SR, Hollingshead BD, Stanton R, Warneke JA, et al. Sequence motifs associated with hepatotoxicity of locked nucleic acid--modified antisense oligonucleotides. Nucleic acids research. 2014;42(8):4882-91. Epub 2014/02/20.
109. Kamola PJ, Maratou K, Wilson PA, Rush K, Mullaney T, McKevitt T, et al. Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs. Molecular therapy Nucleic acids. 2017;8:383-94. Epub 2017/09/18.
110. Bowen JM, Mayo BJ, Plews E, Bateman E, Wignall A, Stringer AM, et al. Determining the mechanisms of lapatinib-induced diarrhoea using a rat model. Cancer chemotherapy and pharmacology. 2014;74(3):617-27. Epub 2014/07/25.
111. Khozin S, Weinstock C, Blumenthal GM, Cheng J, He K, Zhuang L, et al. Osimertinib for the Treatment of Metastatic EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(9):2131-5. Epub 2016/12/08.
112. Pitkanen HT, Oja SS, Kemppainen K, Seppa JM, Mero AA. Serum amino acid concentrations in aging men and women. Amino acids. 2003;24(4):413-21. Epub 2003/05/28.
113. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, Ikeda S, et al. Measurement of internal body time by blood metabolomics. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(24):9890-5. Epub 2009/06/03.
114. Davis JS, Darcy CJ, Piera K, McNeil YR, Woodberry T, Anstey NM. Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: implications for arginine and taurine measurements. BMC clinical pathology. 2009;9:10. Epub 2009/11/28.
115. Takehana S, Yoshida H, Ozawa S, Yamazaki J, Shimbo K, Nakayama A, et al. The effects of pre-analysis sample handling on human plasma amino acid concentrations. Clinica chimica acta; international journal of clinical chemistry. 2016;455:68-74. Epub 2016/02/02.
116. Lee MY, Hu T. Computational Methods for the Discovery of Metabolic Markers of Complex Traits. Metabolites. 2019;9(4). Epub 2019/04/17.
117. Varma VR, Oommen AM, Varma S, Casanova R, An Y, Andrews RM, et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS medicine. 2018;15(1):e1002482. Epub 2018/01/26.
118. Alakwaa FM, Chaudhary K, Garmire LX. Deep Learning Accurately Predicts Estrogen Receptor Status in Breast Cancer Metabolomics Data. Journal of proteome research. 2018;17(1):337-47. Epub 2017/11/08.
論文の公開元へ
